1 Min Read
Aug 18 (Reuters) - Celltrion Inc :
* Says it signed a 56.96 billion won contract with Celltrion Healthcare Co., Ltd to provide biosimilar antibody drug
Source text in Korean: goo.gl/XayB2M
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.